Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. (Q41835603)

From Wikidata
Jump to: navigation, search
scientific article published on 5 July 2016
edit
Language Label Description Also known as
English
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
scientific article published on 5 July 2016

    Statements

    Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. (English)
    1 reference
    Roberto Moretto
    1 reference
    Chiara Cremolini
    1 reference
    Daniele Rossini
    1 reference
    Francesca Battaglin
    1 reference
    Alessia Mennitto
    1 reference
    Francesca Bergamo
    1 reference
    Fotios Loupakis
    1 reference
    Federica Marmorino
    1 reference
    Rosa Berenato
    1 reference
    Valentina Angela Marsico
    1 reference
    Marta Caporale
    1 reference
    Carlotta Antoniotti
    1 reference
    Gianluca Masi
    1 reference
    Lisa Salvatore
    1 reference
    Beatrice Borelli
    1 reference
    Gabriella Fontanini
    1 reference
    Sara Lonardi
    1 reference
    Alfredo Falcone
    1 reference
    5 July 2016
    1 reference
    21
    1 reference
    988-994
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit